Maryland shields veterinary cannabis consultations from discipline

Maryland has joined the growing list of states giving veterinarians legal cover to talk with clients about cannabis. Under House Bill 452, which took effect October 1, 2026, the State Board of Veterinary Medical Examiners can no longer discipline a veterinarian solely for discussing or recommending cannabis or CBD products for an animal’s potential therapeutic effect or health supplementation. The law is narrow but meaningful: it protects the conversation itself, not broader clinical conduct. (mgaleg.maryland.gov)

The measure became Chapter 47 after Gov. Wes Moore approved it on April 14, 2026, following introduction in January and companion consideration as SB 54. The statutory change amends Maryland’s veterinary disciplinary framework rather than creating a veterinary cannabis program. That distinction matters because it leaves the rest of the board’s authority intact, including discipline tied to negligence, incompetence, or other violations. (mgaleg.maryland.gov)

The backdrop is familiar across companion animal practice: pet parents are already using or considering cannabinoid products, while veterinarians have faced legal uncertainty about how much they can say. Maryland board records from late 2025 reflected that tension, noting inquiries about whether practices could discuss cannabis-based products and indicating that Maryland legality did not then extend to veterinarians. By August 2026, the board’s public meeting agenda included implementation guidance for Chapter 48/SB 54 and HB 452, showing regulators were preparing for the shift before the October effective date. (mda.maryland.gov)

The bill text is specific. It prohibits the board from suspending or revoking a license, reprimanding or censuring a licensee, or placing a licensee on probation solely because the licensee discussed or recommended cannabis, as defined in Maryland law, or a product containing cannabidiol for an animal. It does not say veterinarians may prescribe cannabis, and it does not amount to state approval of cannabis products for animal use. dvm360 noted that regulators still have not approved cannabis for use in animals and cannot assure safety or effectiveness of products marketed for them. (mgaleg.maryland.gov)

Industry support appears to have helped move the bill. Reporting cited backing from the Maryland Veterinary Medical Association, and committee testimony from attorney Jill Cohen Roth argued that the need was urgent because veterinarians risked professional discipline for discussions clients were already initiating. At the same time, Roth urged lawmakers to refine the language so it would not blur the line between veterinary advice and Maryland’s separate human medical cannabis recommendation system, favoring terms such as educating, guiding, and advising. That tension may shape future guidance. (theherd.news)

Why it matters: For veterinary professionals, the immediate value is risk reduction around client communication. In practice, that means Maryland veterinarians should be better positioned to discuss known evidence gaps, possible adverse effects, product variability, drug interactions, and the difference between hemp-derived CBD products and higher-THC cannabis products without fearing discipline based on the conversation alone. Just as important, the law may support better documentation and safer case management when pet parents are already administering these products at home. (mgaleg.maryland.gov)

The bigger picture is that Maryland is not creating a comprehensive framework for veterinary cannabinoid medicine; it is carving out speech protection inside an unsettled regulatory environment. Federal and state cannabis policy continues to evolve, and Maryland’s cannabis administration has separately noted that state law remains in force as federal rescheduling developments proceed. That leaves veterinarians operating in a market where client demand is real, product oversight is uneven, and formal animal-specific approvals remain limited. (cannabis.maryland.gov)

What to watch: The next signals will likely come from board guidance and continuing education, not from a sudden expansion of prescribing authority. Watch for Maryland to clarify expectations around the veterinarian-client-patient relationship, recordkeeping, and how clinicians should frame recommendations versus general counseling. Longer term, the key question is whether more states follow with similar protections, or whether Maryland revisits the law to define consultation standards more explicitly. (news.maryland.gov)